ARPHOS

This brand name is authorized in France.

Active ingredients

The drug ARPHOS contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Magnesium oxide UNII `T42NAD2KHC` - MAGNESIUM GLUCONATE
	Magnesium oxide (MgO), or magnesia, is an empirical formula of MgO and consists of a lattice of Mg2+ ions and O2− ions held together by ionic bonding.
	Read more about Magnesium oxide
`2`	Calcium glycerophosphate UNII `XWV9Z12C1C` - CALCIUM GLYCEROPHOSPHATE
	Read more about Calcium glycerophosphate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A13A	Tonics	A Alimentary tract and metabolism → A13 Tonics
Discover more medicines within A13A

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FR	Base de données publique des médicaments	65979518

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.